Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways

Gastroenterology

Volumn 128, Issue 1, 2005, Pages 86-95

  Shao, Run Xuan ^a   Otsuka, Motoyuki ^a   Kato, Naoya ^a   Taniguchi, Hiroyoshi ^a   Hoshida, Yujin ^a   Moriyama, Masaru ^a   Kawabe, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; RETINOID; RHO FACTOR; SERUM RESPONSE FACTOR;

ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG INHIBITION; EXAMINATION; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MODULATION; MOLECULE; PRIORITY JOURNAL; REPORTER GENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 11144252700     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.077     Document Type: Article

References (48)

1. F. Wong, T.K. Choi Primary liver cancer. Asian experience L.H. Blumgart Surgery of liver and biliary tract 1998 Churchill-Livingstone London 1135 1151
2. H.B. El-Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 2002 S74 S83
3. M. Omata, H. Yoshida Prevention and treatment of hepatocellular carcinoma Liver Transpl 10 2004 S111 S114
4. H.P. Allgaier, D. Galandi, I. Zuber, H.E. Blum Radiofrequency thermal ablation of hepatocellular carcinoma Dig Dis 19 2001 301 310
5. S. Shiina, T. Teratani, S. Obi, K. Hamamura, Y. Koike, M. Omata Nonsurgical treatment of hepatocellular carcinoma from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation Oncology 62 2002 64 68
6. T.Y. Lin, C.S. Lee, K.M. Chen, C.C. Chen Role of surgery in the treatment of primary carcinoma of the liver a 31-year experience Br J Surg 74 1987 839 842
7. M. Pompili, G.L. Rapaccini, M. Covino, G. Pignataro, E. Caturelli, D.A. Siena, M.R. Villani, A. Cedrone, G. Gasbarrini Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy Cancer 92 2001 126 135
8. Y. Shiratori, S. Shiina, T. Teratani, M. Imamura, S. Obi, S. Sato, Y. Koike, H. Yoshida, M. Omata Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus Ann Intern Med 138 2003 299 306
9. Y. Muto, H. Moriwaki, M. Ninomiya, S. Adachi, A. Saito, K.T. Takasaki, T. Tanaka, K. Tsurumi, M. Okuno, E. Tomita, T. Nakamura, T. Kojima Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group N Engl J Med 334 1996 1561 1567
10. M. Suzui, M. Masuda, J.T. Lim, C. Albanese, R.G. Pestell, I.B. Weinstein Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1 Cancer Res 62 2002 3997 4006
11. M. Suzui, M. Shimizu, M. Masuda, J.T. Lim, N. Yoshimi, I.B. Weinstein Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21 (CIP1) in HepG2 human hepatoma cells Mol Cancer Ther 3 2004 309 316
12. M. Ohashi, F. Kanai, H. Ueno, T. Tanaka, K. Tateishi, T. Kawakami, Y. Koike, T. Ikenoue, Y. Shiratori, H. Hamada, M. Omata Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo Gut 44 1999 366 371
13. E. Schreiber, P. Matthias, M.M. Muller, W. Schaffner Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells Nucleic Acids Res 17 1989 6419
14. M.D. Wheeler, O.M. Smutney, J.F. Check, I. Rusyn, R. Schulte-Hermann, R.G. Thurman Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy Am J Physiol 284 2003 G302 G312
15. B. Govindarajan, X. Bai, C. Cohen, H. Zhong, S. Kilroy, G. Louis, M. Moses, J.L. Arbiser Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling J Biol Chem 278 2003 9790 9795
16. V. Korinek, N. Barker, P.J. Morin, D. van Wichen, R. de Weger, K.W. Kinzler, B. Vogelstein, H. Clevers Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma Science 275 1997 1784 1787
17. D.G. McEwen, D.M. Ornitz Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors J Biol Chem 273 1998 5349 5357
18. T. Ishikawa, T. Igarashi, K. Hata, T. Fujita c-fos induction by heat, arsenite, and cadmium is mediated by a heat shock element in its promoter Biochem Biophys Res Commun 254 1999 566 571
19. H. Niwa, K. Yamamura, J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
20. N. Kato, H. Yoshida, S. Kioko Ono-Nita, J. Kato, T. Goto, M. Otsuka, K. Lan, K. Matsushima, Y. Shiratori, M. Omata Activation of intracellular signaling by hepatitis B and C viruses C-viral core is the most potent signal inducer Hepatology 32 2000 405 412
21. M. Otsuka, Y. Hoshida, N. Kato, M. Moriyama, H. Taniguchi, M. Arai, M. Mori, N. Seki, M. Omata Liver chip and gene shaving J Gastroenterol 38 2003 89 92
22. M. Moriyama, Y. Hoshida, M. Otsuka, S. Nishimura, N. Kato, T. Goto, H. Taniguchi, Y. Shiratori, N. Seki, M. Omata Relevance network between chemosensitivity and transcriptome in human hepatoma cells Mol Cancer Ther 2 2003 199 205
23. H. Aizaki, T. Harada, M. Otsuka, N. Seki, M. Matsuda, Y.W. Li, H. Kawakami, Y. Matsuura, T. Miyamura, T. Suzuki Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame Hepatology 36 2002 1431 1438
24. A. Brazma, P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C.A. Ball, H.C. Causton, T. Gaasterland, P. Glenisson, F.C. Holstege, I.F. Kim, V. Markowitz, J.C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-Kremer, J. Stewart, R. Taylor, J. Vilo, M. Vingron Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat Genet 29 2001 365 371
25. M.K. Webster, D.J. Donoghue Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain Mol Cell Biol 17 1997 5739 5747
26. A.J. Whitmarsh, P. Shore, A.D. Sharrocks, R.J. Davis Integration of MAP kinase signal transduction pathways at the serum response element Science 269 1995 403 407
27. Y. Ling, A.G. West, E.C. Roberts, J.H. Lakey, A.D. Sharrocks Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface J Biol Chem 273 1998 10506 10514
28. J. Liao, C. Hodge, D. Meyer, P.S. Ho, K. Rosenspire, J. Schwartz Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element J Biol Chem 272 1997 25951 25958
29. C.S. Hill, J. Wynne, R. Treisman The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF Cell 81 1995 1159 1170
30. J.A. Spencer, M.L. Major, R.P. Misra Basic fibroblast growth factor activates serum response factor gene expression by multiple distinct signaling mechanisms Mol Cell Biol 19 1999 3977 3988
31. K. Burridge, M. Chrzanowska-Wodnicka Focal adhesions, contractility, and signaling Annu Rev Cell Dev Biol 12 1996 463 518
32. A. Sotiropoulos, D. Gineitis, J. Copeland, R. Treisman Signal-regulated activation of serum response factor is mediated by changes in actin dynamics Cell 98 1999 159 169
33. D.M. Ornitz, J. Xu, J.S. Colvin, D.G. McEwen, C.A. MacArthur, F. Coulier, G. Gao, M. Goldfarb Receptor specificity of the fibroblast growth factor family J Biol Chem 271 1996 15292 15297
34. Z. Galzie, A.R. Kinsella, J.A. Smith Fibroblast growth factors and their receptors Biochem Cell Biol 75 1997 669 685
35. Y. Muto, H. Moriwaki, Y. Shiratori Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma Digestion 59 1998 89 91
36. N.E. Olson, J. Kozlowski, M.A. Reidy Proliferation of intimal smooth muscle cells. Attenuation of basic fibroblast growth factor 2-stimulated proliferation is associated with increased expression of cell cycle inhibitors J Biol Chem 275 2000 11270 11277
37. J.R. Brown, E. Nigh, R.J. Lee, H. Ye, M.A. Thompson, F. Saudou, R.G. Pestell, M.E. Greenberg Fos family members induce cell cycle entry by activating cyclin D1 Mol Cell Biol 18 1998 5609 5619
38. D. Gospodarowicz, J.S. Moran Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblasts J Cell Biol 66 1975 451 457
39. L. Schweigerer, G. Neufeld, J. Friedman, J.A. Abraham, J.C. Fiddes, D. Gospodarowicz Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth Nature 325 1987 257 259
40. M. Presta, D. Moscatelli, J. Joseph-Silverstein, D.B. Rifkin Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration Mol Cell Biol 6 1986 4060 4066
41. Y. Motoo, N. Sawabu, Y. Nakanuma Expression of epidermal growth factor and fibroblast growth factor in human hepatocellular carcinoma an immunohistochemical study Liver 11 1991 272 277
42. J.A. Takahashi, H. Mori, M. Fukumoto, K. Igarashi, M. Jaye, Y. Oda, H. Kikuchi, M. Hatanaka Gene expression of fibroblast growth factors in human gliomas and meningiomas demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues Proc Natl Acad Sci U S A 87 1990 5710 5714
43. S. Ogasawara, H. Yano, A. Iemura, T. Hisaka, M. Kojiro Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines Hepatology 24 1996 198 205
44. R.T. Poon, I.O. Ng, C. Lau, W.C. Yu, S.T. Fan, J. Wong Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma Am J Surg 182 2001 298 304
45. Y. Midorikawa, S. Ishikawa, H. Iwanari, T. Imamura, H. Sakamoto, K. Miyazono, T. Kodama, M. Makuuchi, H. Aburatani Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling Int J Cancer 103 2003 455 465
46. N.R. Wall, Y. Shi Small RNA can RNA interference be exploited for therapy? Lancet 362 2003 1401 1403
47. M. Kagawa, T. Sano, N. Ishibashi, M. Hashimoto, M. Okuno, H. Moriwaki, R. Suzuki, H. Kohno, T. Tanaka An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-α expression and cell proliferation Carcinogenesis 25 2004 979 985
48. Y. Muto, H. Moriwaki, M. Omori In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins Gann 72 1981 974 977